6 things you need to know about CMS’ drug price negotiation strategy

CMS on Tuesday announced a list of the first 10 drugs that will be eligible for price negotiations under the Inflation Reduction Act (IRA). What does this tell us about the future of Medicare drug price negotiation? Advisory Board’s Lindsey Paul and Chloe Bakst share six things the selected drugs reveal about CMS’ strategy.

For the first time, Medicare can negotiate drug prices. These talks will start in February 2024, and the maximum negotiated prices will be released in September 2024.

Here’s what the 10 selected drugs reveal about CMS’ overall strategy and the future of Medicare drug price negotiation.

2 things...